Aldeyra Therapeutics, Inc. (ALDX) › Total LiabilitiesAldeyra Therapeutics, Inc. (ALDX) — Total LiabilitiesAnnual figures by fiscal year, from SEC filings.2013: $5.65M2014: $2.50M2015: $3.33M2016: $3.54M2017: $4.57M2018: $8.47M2019: $27.44M2020: $23.84M2021: $27.40M2022: $30.28M2023: $28.53M2024: $33.60M2025: $27.81M$27.81M2013Total Liabilities (USD)2025Fiscal YearTotal LiabilitiesChange YoY2025$27.81M-17.2%2024$33.60M+17.8%2023$28.53M-5.8%2022$30.28M+10.5%2021$27.40M+14.9%2020$23.84M-13.1%2019$27.44M+223.8%2018$8.47M+85.2%2017$4.57M+29.3%2016$3.54M+6.4%2015$3.33M+32.9%2014$2.50M-55.7%2013$5.65M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share